Improving Migraine Screening and Treatment in Black Female Patients: Addressing Gender and Racial Disparities in Migraine Care
Released On
January 6, 2025
Expires On
January 5, 2026
Media Type
Internet
Completion Time
60 minutes
Specialty
Acute Care, Case Management, Emergency Medicine, Ethics, Hospitalist, Integrative Medicine, Neurology, Pain Management, Primary Care
Topic(s)
Health Literacy, Mental Health, Mood Disorders, Pain
This activity is supported in part by an independent education grant from Pfizer.
Credit Available
- Physicians — maximum of 1 AMA PRA Category 1 Credits™
- Nurses — 1 Nursing Contact Hours
All other healthcare professionals completing this course will be issued a statement of participation.
Target Audience
This activity is designed to meet the educational needs of healthcare practitioners involved in the care and treatment of patients with migraine.
Program Overview
This activity will cover racial disparities in migraine care of Black Women.
Learning Objectives
Upon completion of this activity, participants should be better able to:
- Recognize the prevalence of migraine in black/African American patients compared with other patient populations.
- Recognize the racial and gender disparities that exist in diagnosis and treatment of migraine in the United States.
- Discuss the social determinants of health disparities in headache medicine, especially concerning black/African American female patients.
- Identify solutions to mitigate health care disparities in migraine treatment to improve outcomes for black/African American patients with migraine.
Faculty
Cynthia E Armand, MD
Cynthia E. Armand, MD an Associate Professor of Neurology at the Albert Einstein College of Medicine, and Clinical Director and Fellowship Director at the Montefiore Headache Center. She is a member of the American Academy of Neurology (AAN) and American Headache Society (AHS). She was named an Emerging Leader in Headache Medicine by the AHS in 2018. Her awards include the 2016 Frontiers in Headache Research Scholarship as well as being named an Emerging Leader in Headache Medicine by the AHS in 2018. She was inducted into the AAN’s Diversity Leadership Program’s class of 2019-2020. She was appointed as co-chair of the AHS Diversity, Equity, and Inclusion Task Force in 2020 and received the 2023 AHS Above and Beyond Award for her work in that role. She is currently web editor for JAMA Neurology, and the host of their Author Interviews Podcast. Dr. Armand is an avid lover of neurology and health news with a strong interest in patient education as well as social media as a valuable means of patient empowerment and knowledge.
Cynthia E. Armand, MD
Associate Professor of Neurology
Albert Einstein College of Medicine
Program Director, Montefiore Headache Center
1250 Waters Place,Tower II, 8th Floor
Bronx, NY 10461
Larry Charleston IV, M.D., MSc., FAHS
Dr. Larry Charleston IV is Director of the Headache & Facial Pain Division, Director of Faculty Development, Professor of Neurology in Michigan State University College of Human Medicine Department of Neurology and Ophthalmology, and Adjunct faculty at the Jefferson Headache Center. He is certified in Adult Neurology by the American Board of Psychiatry and Neurology and Headache Medicine by the United Council of Neurological Subspecialties. He is founder of Charleston Health Neurology & Head Pain Consultants, Co-founder of Charleston International in partnership with the Amway Corporation and Leadership Team Development, a National Institute of Minority Health and Health Disparities’ Research Institute Scholar, a UM Road Scholar, and a fellow of the American Headache Society. Dr. Charleston currently serves as Treasurer of the Clinical Neurological Society of America and is Chair of the American Headache Society’s Equity Diversity & Inclusion Advisory Council. He enjoys time with his family and is avid songwriter and music producer.
L. Charleston IV, MD, MSc, FAHS
Chief Consultant,
Charleston Health Neurology &
Head Pain Consultants
Pinckney, MI
Professor
Director, Headache Medicine and Facial Pain
Director, Department Faculty Development
Department of Neurology and Ophthalmology
Michigan State University College of Human Medicine
Associate Editor, Headache: The Journal of Head and Facial Pain
Hope O'Brien, MD, MBA, FAHS, FAAN
Dr. Hope O'Brien is a distinguished neurologist and expert in headache medicine, recognized for her significant contributions to the field of neurology and her innovative approach to patient care. She earned her Bachelor of Science in Neuroscience with Honors Distinction for Research from the University of Rochester in New York. Building on this strong foundation, Dr. O'Brien pursued her medical degree at the University of Cincinnati College of Medicine, where she also completed her residency in Adult General Neurology. Following her residency, Dr. O'Brien advanced her expertise through a fellowship in Headache Medicine at Cincinnati Children's Hospital Medical Center. Her dedication and expertise in this area led her to a faculty position at the same institution, where she created and directed the Young Adult Headache Program and directed the Headache Medicine Fellowship. Her work has had a profound impact on the management and treatment of headache disorders. Dr. O'Brien is board certified in both Neurology and Headache Medicine, and she holds an Executive MBA degree, which complements her clinical expertise with strong business acumen. Her research is particularly focused on late adolescents and young adults with headaches, and she has authored over 75 peer-reviewed publications, abstracts, and book chapters. In June 2021, Dr. O'Brien founded the Headache Center of Hope, a pioneering direct-to-consumer and concierge neurology practice dedicated to addressing the needs of patients of all ages suffering from recurrent headaches. This practice reflects her commitment to providing personalized and accessible care. Her leadership extends to several expert committees of prestigious organizations including the American Academy of Neurology (AAN) and the American Headache Society (AHS). Dr. O'Brien serves as the Vice Chair of the Meeting Management Committee of the AAN and the Accreditation Committee of the United Council of Neurological Subspecialties and on the board of the National Headache Foundation. She is also a valued member of the Medscape/AHS Advisory Board Migraine Center of Excellence. In addition to her clinical and administrative roles, Dr. O'Brien is an associate professor volunteer faculty member in Neurology at the University of Cincinnati Collge of Medicine, where she contributes to the education and training of future neurologists. Dr. O’Brien is also known for having candid conversations with the tennis champion, Serena Williams about the athlete’s journey towards migraine treatment and has shared the stage with Tony and Emmy award winner, Kristin Chenoweth, in her advocacy efforts related to migraine awareness! Dr. Hope O'Brien's career reflects a dedication to advancing the field of neurology and improving patient outcomes through innovative research, leadership, and direct patient care.
Hope O'Brien, MD, MBA, FAHS, FAAN
Founder & CEO
Headache Center of Hope
4565 E. Galbraith Rd.
Suite A
Cincinnati, OH 45236
Office: (513) 898-9400 | (844) 909-HOPE
Email: [email protected]
Web: www.hcohcincy.com
Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation
Physician Credit Designation Statement
Postgraduate Institute for Medicine designates this enduring activity for a maximum of 1.0 AMA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
Continuing Nursing Education Statement
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hour.
Disclosure of Financial Relationships
Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified financial relationships are thoroughly vetted and mitigated according to PIM policy. PIM is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity:
Dr. Cynthia E. Armand reports being a consultant for LinPharma and advisory board member for Pfizer.
Dr. Larry Charleston reports having received grant and research support rom Amgen, being a consultant/advisory board member for Allergan/Abbvie, Amgen, Amneal, Aurene, Biohaven, Haleon, LinPharma, Mi-Helper Inc., Pfizer, and Satsuma, and reports having received non-mutual funds stock ownership or stock options as an advisory panel member for Mi-Helper Inc.
Hope O’Brien, MD, MBA, FAHS, FAAN
Dr. O’Brien reports have received Grant/Research Support from AbbVie and Lilly; Speakers Bureau/ Honoraria for non-CME from AbbVie, Lilly, Pfizer, and Scilex; Consultant/Advisory Board for AbbVie, Lilly, and Scilex; being up-to-date for editorial contributions; Honoraria from American Academy of Neurology
Instructions for Participation and Credit
There are no fees for participating and receiving CME credit for this enduring activity. To receive CME credit participants must:
- Read the CME/CE information and faculty disclosures.
- Participate in the online activity.
- Submit the evaluation form.
Certificates will be emailed to the participant.
Course Viewing Requirements
Support Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above
Supporte Phones & Tablets
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above
Disclosure of Unlabeled Use
Postgraduate Institute for Medicine requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
Disclaimer
This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
Contact Information
For CME questions please contact: